What we do
About our project
Pseudomonas aeruginosa causes severe infections in hospitalized patients. The worldwide emergence of carbapenem-resistant P. aeruginosa (CR-PA) makes infections by these pathogens almost untreatable. The World Health Organization now ranks CR-PA highest in the list of ‘urgent threats’. Information for action to prevent further emergence has to come from insight into sources and transmission routes through smart surveillance. At present, a smart surveillance strategy is not available for CR-PA.
Aim of the project
The aim of this project is to develop a globally-applicable smart surveillance strategy to guide action against the spread of CR-PA.
Execution of the project
Since P. aeruginosa prefers moist niches, we will focus on the human-water interface. First, highly sensitive methods to detect CR-PA in specific environmental and human niches will be developed. Subsequently, CR-PA will be collected in three study sites with increasing prevalences of CR-PA, increasingly warmer climates, and different water situations: Rotterdam (The Netherlands), Rome (Italy), Jakarta (Indonesia). CR-PA will be searched for in a variety of niches in the environment outside and inside the hospital, and in healthy humans and hospitalized patients. Whole genome sequencing will be performed to compare the CR-PA from different sources and identify transmission routes.
Our project will provide insight into the relative contribution of the different potential reservoirs of CR-PA to its spread in different settings which will be used for the development of a globally-applicable surveillance strategy for CR-PA to guide preventive actions.
Our research focus
Funds & Grants
Department of Medical Microbiology and Infectious Diseases
- National Institute for Public Health and the Environment, Centre for Infectious Disease Control, Bilthoven, The Netherlands (PI: Heike Schmitt, PhD)
- Universitas Indonesia, Faculty of Medicine, Department of Clinical Microbiology, Jakarta, Indonesia (PI: Anis Karuniawati, PhD)
National Institute for Infectious Diseases “L. Spallanzani”, IRCCS-Clinical Department, Rome, Italy (PI: Prof. Nicola Petrosillo, MD PhD)
Stichting Deltares, Utrecht, The Netherlands (PI: Bas van der Zaan, PhD)
Université Laval Integrative Systems Biology Institute, Fac. Medicine, Québec, Canada (PI: Prof. Roger C. Lévesque)
- General emailaddress firstname.lastname@example.org
- Juliëtte A. Severin, MD PhD (PI) email@example.com
- Prof. Margreet C. Vos, MD PhD firstname.lastname@example.org
- Corné H.W. Klaassen, PhD email@example.com
- Anne voor in 't Holt, PhD firstname.lastname@example.org
- Anneloes van Veen, MSc email@example.com